White House Eyes Ophthalmologist Roberts For FDA; Frist Is Sponsor
This article was originally published in The Gray Sheet
Executive Summary
White House interest in Cornell ophthalmologist Calvin Roberts, MD, indicates that the search for a permanent FDA commissioner is continuing
You may also be interested in...
FDA Management Hierarchy Under Crawford Takes Shape; Alderson Elevated
The appointment of Center for Veterinary Medicine Office of Research Director Norris Alderson, PhD, as senior associate commissioner for science indicates that acting Commissioner Lester Crawford, PhD, is preparing for a prolonged tenure as head of FDA
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.